Zobrazeno 1 - 10
of 216
pro vyhledávání: '"I. Pérez Martínez"'
Autor:
Luis Rodrigo Sáez, D. Fuentes Álvarez, I. Pérez Martínez, N. Álvarez Mieres, P. Niño García, R. de Francisco García, S. Riestra Menéndez, C. Bousoño García, R. Alonso Arias, A. López Vázquez
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 103, Iss 5, Pp 238-243 (2011)
Introduction: celiac disease (CD) is a common autoimmune condition (involves 1-2% of the general population) that develops at any age in life but manifests differently in children and adults. Objectives: to analyze clinical differences in disease exp
Externí odkaz:
https://doaj.org/article/9902de83768745bc9f2d543b6c99a539
Autor:
L. Rodrigo Sáez, I. Pérez Martínez
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 102, Iss 8, Pp 461-465 (2010)
Externí odkaz:
https://doaj.org/article/db41f49f49ef488989d8d892ac89f22c
Autor:
D Muiño, L Carballo-Folgoso, J Ortega-Carriedo, P Flórez-Díez, R de Francisco, I Pérez-Martínez, A Castaño-García, E Fernández-González, C García-Pérez, S Martínez-González, V Rolle, S Riestra
Publikováno v:
Journal of Crohn's and Colitis. 17:i303-i305
Background Immune-mediated inflammatory diseases (IMIDs) involve an increased risk of developing atherosclerotic cardiovascular disease (ASCVD). However, the association between inflammatory bowel disease (IBD) and ASCVD is not well established. Our
Autor:
R M De Francisco Garcia, I Pérez-Martínez, A Castaño-García, M Celada-Sendino, E Fernández-González, C García-Pérez, S Martínez-Gozález, V Rolle, R Queiro, S Alonso-Castro, J Santos-Juanes, M Gueimonde, S Riestra
Publikováno v:
Journal of Crohn's and Colitis. 17:i981-i983
Background The association of several immune-mediated inflammatory diseases (IMIDs) in the same patient is well known. IMID, especially joint and cutaneous diseases, are frequently diagnosed in patients with inflammatory bowel disease (IBD). However,
Autor:
M Chaparro, M García Donday, S Rubio, C Calviño Suarez, A Nuñez Ortiz, M Figueira, S Marín Pedrosa, M Rivero, A Fernández-Clotet, L Madero, M T Diz-Lois Palomares, I Pérez-Martínez, A Ruiz-Cerulla, M Arroyo, M Piqueras, C Suarez Ferrer, M Aguas, M Calvo Moya, I Guerra, P López Serrano, J M Vázquez Morón, L Arias García, M J Casanova, J M Huguet, G Valldosera Gomis, B Zúñiga de Mora-Figueroa, R Armesto, P Martínez Montiel, I Rodríguez-Lago, P Sendra Rumbeu, R Camargo Camero, D Hervías Cruz, G Molina Arriero, M Barreiro-de Acosta, D Acosta, Y Brenes, S Hermida, P Parra, A Garre, J P Gisbert
Publikováno v:
Journal of Crohn's and Colitis. 17:i874-i876
Background Biological drugs used for IBD are detected in breast milk at a concentration below 10% of the maternal serum concentration and have therefore been considered as permitted drugs. However, warnings have recently been published regarding vacc
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
I Guerra Marina, L Bujanda, M Mañosa, I Pérez-Martínez, M J Casanova, L de la Peña, M de Benito, M Rivero, P Varela, L Bernal, A C Franco, Y Ber, M Piqueras, C Tardillo, Á Ponferrada, S Olivares, A J Lucendo, P Gilabert, M Sierra Ausín, M Bellart, A Herrarte, M Calafat, R de Francisco, J P Gisbert, J Guardiola, E Domènech, F Bermejo
Publikováno v:
Journal of Crohn's and Colitis. 17:i519-i520
Background An increased risk of lymphoma has been described in patients with Inflammatory Bowel Disease (IBD). The aims of our study were to determine the clinical presentation of lymphoma, previous exposure to immunosuppressive and biologic therapie
Autor:
M Calafat Sard, C Súria, F Mesonero, R de Francisco, C Yagüe Caballero, L de la Peña, A Hernández-Camba, A Marcè, B Gallego, N Martín-Vicente, M Rivero, M Iborra, I Guerra, M Carrillo-Palau, L Madero, B Burgueño, D Montfort, G Torres, M Teller, J Á Ferrer Rosique, P Vega Villaamil, C Roig, Á Ponferrada, E Betoré Glaría, Y Zabana, J P Gisbert, N Alcaide, B Camps, J Legido, M González Vivo, M M Bosca-Watts, I Pérez-Martínez, D Casas Deza, J Guardiola, L Arranz Hernández, M Navarro, F Gomollon, F Cañete, M Mañosa, E Domènech
Publikováno v:
Journal of Crohn's and Colitis. 17:i80-i81
Background The coexistence of immune-mediated diseases and non-pharmacological immunosuppression states are rare and might determine the natural history of the disease and therapeutic decisions of the physician. IBD guidelines recommend screening for
Autor:
M Gonzalez Vivo, M Urpí Ferreruela, B Castro Senosiain, I Pérez-Martínez, J Barrio, L Codesido Prado, B Caballol Oliva, V Pedrera Roman, M Piqueras Cano, F Rodríguez Moranta, M J Casanova González, L Ramos, M Iborra, C Tardillo Marin, M Barreiro-de Acosta, R H Lorente Poyatos, B Orts Jorquera, L Bujanda Fernández, Y Zabana, A López-García, S Riestra, P Vega-Villaamil, M Montoro, J P Gisbert, P Nos, G E Rodriguez Gonzalez, M Porto Silva, A Gutiérrez-Casbas, E Domenech, L Márquez
Publikováno v:
Journal of Crohn's and Colitis. 16:i208-i210
Background Patients with inflammatory bowel disease (IBD) are often classified as ulcerative colitis (UC) and Crohn’s disease (CD). However, in some cases this categorization is not possible and these patients are labelled as inflammatory bowel dis